TREM1 and neoplasm: Enrichment of pathways involved in macrophage classical and alternative activation, such as TREM1 signaling, and cytokine storm responses suggests that model immune cells acquire a mixed activation state supporting both inflammation and immune suppression, i.e., hallmarks of tumor-promoting macrophages.